<?xml version="1.0" encoding="UTF-8"?>
<ref id="B94-ijms-21-03492">
 <label>94.</label>
 <element-citation publication-type="journal">
  <person-group person-group-type="author">
   <name>
    <surname>Li</surname>
    <given-names>H.S.</given-names>
   </name>
   <name>
    <surname>Kuok</surname>
    <given-names>D.I.T.</given-names>
   </name>
   <name>
    <surname>Cheung</surname>
    <given-names>M.C.</given-names>
   </name>
   <name>
    <surname>Ng</surname>
    <given-names>M.M.T.</given-names>
   </name>
   <name>
    <surname>Ng</surname>
    <given-names>K.C.</given-names>
   </name>
   <name>
    <surname>Hui</surname>
    <given-names>K.P.Y.</given-names>
   </name>
   <name>
    <surname>Peiris</surname>
    <given-names>J.S.M.</given-names>
   </name>
   <name>
    <surname>Chan</surname>
    <given-names>M.C.W.</given-names>
   </name>
   <name>
    <surname>Nicholls</surname>
    <given-names>J.M.</given-names>
   </name>
  </person-group>
  <article-title>Effect of interferon alpha and cyclosporine treatment separately and in combination on Middle East Respiratory Syndrome Coronavirus (MERS-CoV) replication in a human in-vitro and ex-vivo culture model</article-title>
  <source>Antivir. Res.</source>
  <year>2018</year>
  <volume>155</volume>
  <fpage>89</fpage>
  <lpage>96</lpage>
  <pub-id pub-id-type="doi">10.1016/j.antiviral.2018.05.007</pub-id>
  <pub-id pub-id-type="pmid">29772254</pub-id>
 </element-citation>
</ref>
